BGI Genomics Co., Ltd. (SHE:300676)

Market Cap	18.46B +23.9%
Revenue (ttm)	3.71B -7.9%
Net Income	-799.91M
EPS	-1.93
Shares Out	383.85M
PE Ratio	n/a
Forward PE	734.70
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,721,247
Average Volume	7,932,575
Open	49.04
Previous Close	49.22
Day's Range	47.90 - 49.20
52-Week Range	43.25 - 70.30
Beta	0.85
RSI	41.94
Earnings Date	Apr 25, 2026

About BGI Genomics

BGI Genomics Co., Ltd. engages in the provision of genomic sequencing services and proteomic services to academic institutions, pharmaceutical companies, health care providers and other organizations in China and internationally. The company offers DNA sequencing services covering whole genome sequencing, plant/animal whole genome sequencing, exome sequencing, de novo sequencing, and metagenomic sequencing; and mass spectrometry services, such as proteomic services and biologics characterization services. It also provides diagnostics and precis...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1999
• Employees: 3,702
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300676